Search Results 61-70 of 23929 for B cell lymphomas

  1. Mantle cell lymphoma - Diagnosis and treatment - Mayo Clinic

    There the CAR-T cells find and destroy the mantle cell lymphoma cells. ... B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn ...

  2. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

    Histologically proven large B-cell lymphoma including the following types defined by WHO 2016 (Swerdlow et al., 2016): · Relapsed or refractory disease after ...

  3. A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    The purpose of tis study is to evaluate whether adding brentuximab vedotin helps two drugs work better to treat patients with diffuse large B-cell lymphoma ( ...

  4. Non Clinical Trials - Mayo Clinic Research

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...

  5. Central Nervous System (CNS) Lymphoma Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine how well nivolumab with or without varlilumab works in treating patients with aggressive B-cell lymphomas that have ...

  6. Overview - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    These conditions include such cancers as multiple myeloma, Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), and such precursor conditions as monoclonal ...

  7. A Phase I/II Study Of AZD4512 Monotherapy Or In Combination With Anticancer Agents In Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell Non-Hodgkin Lymphoma (B-NHL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  8. Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) - Mayo Clinic

    ... B-cell Lymphoma (R/R DLBCL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  9. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    T-cell/histiocyte-rich large B cell lymphoma. Large B-cell lymphoma with ... FDG-nonavid lymphomas: Measurable disease with CT (or MRI) scan with ...

  10. Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and researchers are studying B-cell lymphomas to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is ...